Home
News
Create
Screeners
Insights
Ishita Drugs & Indus
71.
16
-0.21
(-0.29%)
Market Cap
₹21.24 Cr
PE Ratio
24.03
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.29%
1M
+0.91%
6M
-3.94%
1Y
-2.19%
5Y
+116.29%
View Company Insights
Latest news about Ishita Drugs & Indus
Ishita Drugs and Industries Limited Files SEBI Disclosure for Substantial Acquisition
6 days ago
Ishita Drugs and Industries Limited has filed a disclosure under SEBI Regulation 29(2) for substantial acquisition involving Ishita Pharmaceuticals as acquirer. The filing mentions 30,550 shares and indicates the acquirer is a related party to the target company. The disclosure, digitally signed by key personnel, demonstrates regulatory compliance for the transaction involving shares listed on BSE Limited.
Ishita Drugs Q3FY26 Results: Revenue Falls 24% to ₹313.62 Lakhs
Feb 07, 2026
Ishita Drugs & Industries Ltd Schedules Board Meeting on February 07, 2026 for Q3FY26 Financial Results
Jan 30, 2026
Ishita Drugs & Industries Promoter Jagdish Agrawal Acquires Additional 254 Shares
Dec 31, 2025
Ishita Drugs & Industries Reports Mixed Q2 Results, Progresses on Facility Upgrade
Nov 11, 2025
More news about Ishita Drugs & Indus
17
Sept 25
Ishita Pharmaceuticals Increases Stake in Ishita Drugs & Industries to 1.02%
Ishita Pharmaceuticals has increased its stake in Ishita Drugs & Industries to 1.02% through an additional acquisition of 560 shares worth Rs. 10.00 each on December 08, 2025. This follows earlier investments, bringing the total holding to 30,550 shares from the previous 29,990 shares, representing continued strategic interest between the related pharmaceutical companies.
Ishita Drugs & Indus
71.
16
-
0.
21
(-
0.
29
%)
1 Year Returns:
-2.19%
Industry Peers
Sun Pharmaceutical
1,724.40
(+
0.
64
%)
Divis Laboratories
6,291.00
(-
0.
10
%)
Torrent Pharmaceuticals
4,241.70
(+
0.
36
%)
Cipla
1,341.10
(+
0.
92
%)
Dr Reddys Laboratories
1,280.40
(-
0.
15
%)
Lupin
2,219.40
(-
0.
42
%)
Zydus Life Science
900.75
(-
0.
18
%)
Mankind Pharma
2,024.30
(-
0.
75
%)
Aurobindo Pharma
1,158.80
(-
1.
08
%)
Alkem Laboratories
5,392.00
(+
0.
28
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation